Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and
Susan Wee1, Christoph Lengauer, Dmitri Wiederschain
1Novartis Institute for Biomedical Research, Cambridge, Massachusetts 02319, USA. susan.wee@novartis.com
Purpose Of Review:
The phosphoinositide 3-kinases are lipid kinases that are activated in response to external factors. They regulate a number of intracellular signaling pathways involved in cell motility, metabolism, survival, and growth. This review summarizes the current knowledge about specific contributions of Class IA phosphoinositide 3-kinases to tumorigenesis and presents a rationale for the development of isoform-specific inhibitors.
Recent Findings:
In the last decade, the Class IA phosphoinositide 3-kinases have gained considerable attention as drug targets for the treatment of cancer. Indeed, pan-phosphoinositide 3-kinase inhibitors are being evaluated in early phases of clinical trials for the treatment of multiple human malignancies. Accumulating evidence suggests that selectively targeting individual isoforms is also possible. However, the patient population that is most likely to benefit from such selective compounds remains to be elucidated.
Summary:
Given the importance of the phosphoinositide 3-kinase pathway in the initiation and maintenance of human tumors, drugs that effectively target its constituents will be an invaluable addition to the arsenal of anticancer therapeutics. However, to fully capitalize on the central role of this pathway in malignancy, we must first fully understand the nuances of its multiple players.
Insights
Class IA phosphoinositide 3-kinases (PI3Ks) are crucial in cancer development. Understanding these lipid kinases is key to developing targeted therapies for improved cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phosphoinositide 3-kinases (PI3Ks) are lipid kinases activated by external stimuli.
- They regulate critical cellular processes including motility, metabolism, survival, and growth.
- Class IA PI3Ks are implicated in various intracellular signaling pathways.
Purpose of the Study:
- To review the role of Class IA PI3Ks in tumorigenesis.
- To present a rationale for developing isoform-specific PI3K inhibitors.
- To highlight PI3Ks as significant drug targets in cancer therapy.
Main Methods:
- Literature review of current knowledge on Class IA PI3Ks.
- Analysis of their contribution to cancer initiation and progression.
- Evaluation of existing and potential therapeutic strategies.
Main Results:
- Class IA PI3Ks are recognized as key drug targets for cancer treatment.
- Pan-PI3K inhibitors are under clinical investigation for multiple cancers.
- Evidence supports the potential for isoform-specific PI3K inhibition, though optimal patient populations are yet to be defined.
Conclusions:
- Targeting the PI3K pathway offers a promising therapeutic avenue for cancer.
- Further understanding of PI3K pathway components is essential for effective anticancer drug development.
- Isoform-specific inhibitors hold potential, but require further research to identify patient subgroups.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
01:42Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:54Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...